Vimarsana
Biggest News Aggregation in the World

Page 4 - Generate Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Generate Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Generate Life Sciences Today - Breaking & Trending Today

Australian PE firm CPE sells cord blood banking business Cell Care to Generate Life Sciences - Vimarsana News

Australian PE firm CPE sells cord blood banking business Cell Care to Generate Life Sciences

Australian middle-market PE firm CPE has agreed to sell Cell Care Group, its cord blood banking business, to Generate Life Sciences.

Cell Care Joins the Generate Life Sciences Family to Create a Global Platform - Vimarsana News

Cell Care Joins the Generate Life Sciences Family to Create a Global Platform

The acquisition provides the companies with shared scientific knowledge and resources leading to a stronger foundation for advancing newborn stem...

Insception Lifebank and Cells for Life Join the Generate Life Sciences Family to Create a Global Platform - Vimarsana News

Insception Lifebank and Cells for Life Join the Generate Life Sciences Family to Create a Global Platform

The Cell Care international umbilical cord blood and tissue banking group, which incorporates Insception Biosciences Inc. (Insception) in Canada, today announced that it has been acquired by Generate Life Sciences (Generate).* Generate operates Cord Blood Registry (CBR), North America's largest cord blood bank and one of the world's preeminent stem cell R&D organizations. Insception joins CBR to create a unique, international scientific collaboration to further newborn stem cell and regenerative

Source: yahoo.com
The Generate Life Sciences Family of Companies Grows With the Addition of the Cell Care Group of Cord Blood Banks - Vimarsana News

The Generate Life Sciences Family of Companies Grows With the Addition of the Cell Care Group of Cord Blood Banks

/PRNewswire/ -- Generate Life Sciences (Generate) today announced that it has acquired the Cell Care international cord blood banking group (Cell Care), which...

Mesenchymal Stem Cells Market Size Worth $6.1 Billion By 2028: Grand View Research, Inc. - Vimarsana News

Mesenchymal Stem Cells Market Size Worth $6.1 Billion By 2028: Grand View Research, Inc.

Share this article SAN FRANCISCO, May 19, 2021 /PRNewswire/ -- The global mesenchymal stem cells market size is expected to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.6% from 2021 to 2028. Mesenchymal stem cells (MSCs) are set to gain popularity among healthcare professionals, to develop novel therapeutics, primarily targeted at the treatment of several immune-mediated disorders. MSCs have been acclaimed effective as a regenerative therapy for skeletal tissue repair and have recently gained tracti...